Clinical trial support services are distinguishing services used by pharmaceutical companies during the clinical trials of any new drugs or molecular analysis of generics and biosimilars before their introduction in the market. Thus, with the increasing number of clinical trials across the globe, the demand for clinical trials support services is also increasing rapidly.
Increasing prevalence of chronic/infectious disease, increase in drug discovery and development, increasing number of clinical trials, and increasing demand for clinical trials support services are major factors expected to driver growth of the global clinical trials support servicesmarket during the forecast period. For instance, According to the World Health Organization (WHO), there was a steady rise in the number of newly recruiting trials registered on the International Clinical Trials Registry Platform (ICTRP) for most WHO regions. The U.S. had a highest total number of trials registered during 1999-2022 (168,520), followed by China (94,193) and Japan (63,499).
However, stringent regulatory framework and poor healthcare infrastructure is expected to hamper the growth of the global clinical trials support services market.
- This report provides in-depth analysis of the global clinical trials support servicesmarket, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global clinical trials support servicesmarket based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Wuxi AppTec, Inc., Syneos Health, Inc., Eurofins Scientific, Laboratory Corporation of America Holdings (Labcorp), Icon PLC, ALCURA, IQVIA Holdings, Inc., Parexel International Corporation, PPD, Inc. (Pharmaceutical Product Development), and Charles River Laboratories International, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global clinical trials support servicesmarket report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical trials support servicesmarket.
-
- Phase I
- Phase II
- Phase III
- Phase IV
-
- Clinical Trial Site Management
- Patient Recruitment Management
- Data Management
- Administrative Staff
- IRB
- Others
-
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Wuxi AppTec, Inc.
- IQVIA Holdings, Inc.
- Syneos Health, Inc.
- Eurofins Scientific
- Laboratory Corporation of America Holdings (Labcorp)
- Icon PLC
- ALCURA
- Parexel International Corporation
- PPD, Inc. (Pharmaceutical Product Development)
- Charles River Laboratories International, Inc.
